SHIELDED LIVING THERAPEUTICS Canadian Trademark Information

On Friday, May 10, 2019, a canadian trademark registration was filed for SHIELDED LIVING THERAPEUTICS by Sigilon Therapeutics, Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1962316. The current status of this trademark filing is Registration published. The SHIELDED LIVING THERAPEUTICS trademark is filed in the description of Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use , Chemical agents for coating of medical devices and medical materials for use in the research, discovery and development of implantable medical devices, medical materials and cell therapies; reagents for research purposes in the nature of polymers, chemical compounds and genetically modified cells; reagents for scientific and medical research use in the nature of polymers, chemical compounds and genetically modified cells. , Chemical agents for coating of medical devices and medical materials; reagents for research purposes; reagents for scientific or medical research use , Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells , Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response to cellular therapies; chemical agents for pharmaceutical and medical purposes, namely, pharmaceutical agents for modulating immune response to encapsulated cellular therapies; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, chronic inflammation associated with diseases and disorders, cancer, and infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells. , Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for modulating immune response; chemical agents for pharmaceutical or medical purposes, namely, pharmaceutical agents for modulating immune response; pharmaceutical agents for encapsulating transplanted cells to prevent the risk of rejection from immune attack, for medical purposes; pharmaceutical preparations for the prevention and treatment of fibrosis, inflammation, cancer or infection; drug delivery agents in the form of coatings for capsules that facilitate the tolerance and delivery of pharmaceutical preparations; chemical agents, namely, drug delivery agents in the form of coatings that facilitate the delivery of pharmaceutical agents and cells .